- Home
- MSGM vs CNSP Comparison
MSGM vs CNSP Comparison
Compare MSGM & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGM
- CNSP
- Stock Information
- Founded
- MSGM 2018
- CNSP 2017
- Country
- MSGM United States
- CNSP United States
- Employees
- MSGM N/A
- CNSP N/A
- Industry
- MSGM Computer Software: Prepackaged Software
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- MSGM Technology
- CNSP Health Care
- Exchange
- MSGM Nasdaq
- CNSP Nasdaq
- Market Cap
- MSGM 5.0M
- CNSP 5.4M
- IPO Year
- MSGM 2021
- CNSP 2019
- Fundamental
- Price
- MSGM $1.11
- CNSP $0.11
- Analyst Decision
- MSGM Hold
- CNSP Strong Buy
- Analyst Count
- MSGM 1
- CNSP 1
- Target Price
- MSGM $5.00
- CNSP $0.50
- AVG Volume (30 Days)
- MSGM 19.7K
- CNSP 41.4M
- Earning Date
- MSGM 11-14-2024
- CNSP 11-15-2024
- Dividend Yield
- MSGM N/A
- CNSP N/A
- EPS Growth
- MSGM N/A
- CNSP N/A
- EPS
- MSGM 1.82
- CNSP N/A
- Revenue
- MSGM $8,460,953.00
- CNSP N/A
- Revenue This Year
- MSGM $23.00
- CNSP N/A
- Revenue Next Year
- MSGM $72.82
- CNSP N/A
- P/E Ratio
- MSGM $0.61
- CNSP N/A
- Revenue Growth
- MSGM N/A
- CNSP N/A
- 52 Week Low
- MSGM $1.01
- CNSP $0.10
- 52 Week High
- MSGM $4.16
- CNSP $137.50
- Technical
- Relative Strength Index (RSI)
- MSGM 34.18
- CNSP 37.06
- Support Level
- MSGM $1.19
- CNSP $0.10
- Resistance Level
- MSGM $1.27
- CNSP $0.13
- Average True Range (ATR)
- MSGM 0.06
- CNSP 0.02
- MACD
- MSGM -0.01
- CNSP 0.00
- Stochastic Oscillator
- MSGM 0.00
- CNSP 8.50
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.